Citation:
齐磊, 韩青兵, 王可. 贝伐珠单抗导致心肌梗死一例. Chinese Journal of Respiratory and Critical Care Medicine, 2018, 17(6): 622-623. doi: 10.7507/1671-6205.201703035
Copy
Copyright © the editorial department of Chinese Journal of Respiratory and Critical Care Medicine of West China Medical Publisher. All rights reserved
1. |
余文韬, 王怡鑫, 蒋刚. 贝伐珠单抗不良反应的文献计量分析. 中国药房, 2017, 28(2): 190-193.
|
2. |
季发和, 朴瑛, 谢晓冬, 等. 贝伐珠单抗联合化疗致下肢深静脉血栓形成一例并文献复习. 临床误诊误治, 2016, 29(12): 7-9.
|
3. |
张莉. 贝伐单抗致不良反应统计分析. 临床医学工程, 2012, 19(1): 129-130.
|
4. |
Scappaticci FA, Skillings JR, Holden SN, et al. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst, 2007, 99(16): 1232-1239.
|
5. |
Nalluri SR, Chu D, Keresztes R, et al. Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA, 2008, 300(19): 2277-2285.
|
- 1. 余文韬, 王怡鑫, 蒋刚. 贝伐珠单抗不良反应的文献计量分析. 中国药房, 2017, 28(2): 190-193.
- 2. 季发和, 朴瑛, 谢晓冬, 等. 贝伐珠单抗联合化疗致下肢深静脉血栓形成一例并文献复习. 临床误诊误治, 2016, 29(12): 7-9.
- 3. 张莉. 贝伐单抗致不良反应统计分析. 临床医学工程, 2012, 19(1): 129-130.
- 4. Scappaticci FA, Skillings JR, Holden SN, et al. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst, 2007, 99(16): 1232-1239.
- 5. Nalluri SR, Chu D, Keresztes R, et al. Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA, 2008, 300(19): 2277-2285.